Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Too Few Diabetes Trials are Seeking Answers to Issues Important to Patients, Including Hard CV End P
Link ID 6319
Title Too Few Diabetes Trials are Seeking Answers to Issues Important to Patients, Including Hard CV End P
Url http://www.medscape.com/viewarticle/575544?src=rss
Description In over 400 randomized trials, less than one-fifth included CV events, death, pain, function, or another quality-of-life end point as the primary-outcome measure. Researchers say a consensus initiative is warranted to mandate hard clinical end points in major trials. Heartwire
Category Articles > Cardiology
Keywords
Date Jun 6, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Cardiology
1. Culotte Stenting Slightly Superior to Crush Technique in Bifurcated Lesions
  Investigators report that the limited restenoses that did result occurred in side branches, a problem more common with the crush technique, and that culotte bifurcation stenting resulted in a single-digit restenosis rate, suggesting it might be preferred in suitable anatomy. Heartwire
Category:   Articles > Cardiology


2. Critical Updates: The Role of Atherosclerosis, Hypertension and Diabetes in Cardiovascular Disease:
  Review the interactions of atherosclerosis, diabetes, and obesity in cardiovascular disease.
Category:   Articles > Cardiology


3. Omega-3 Fatty Acids, but Not Statin Therapy, Cuts Mortality and Hospitalizations in Heart Failure
  Omega-3 fatty-acid supplementation improved morbidity and mortality in symptomatic heart-failure patients, while statins failed to have any beneficial effect in the same group of patients. Medscape Medical News
Category:   Articles > Cardiology


4. Thiazides First-Choice Antihypertensive Even for Patients With Metabolic Syndrome
  New findings from a heart trial do not support a preference for calcium blockers, alpha-blockers, or angiotensin-converting enzyme inhibitors vs thiazide diuretics in patients with metabolic syndrome. Medscape Medical News
Category:   Articles > Cardiology


5. Transapical Valve Data: Climbing Survival Rates Speak to Improved Skill, Technology, and Patient Sel
  Surgeons say the bleak six-month survival rate of 55% in the preapproval PARTNER EU data set reflects the learning-curve period. Refinements to the technology, growing expertise, and better patient selection are captured in the later SOURCE data set and those of single European centers, where 30-day survival approaches 90%. Heartwire
Category:   Articles > Cardiology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS